Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCT in refractory primary Sjögren's syndrome
NCT00953485Phase 2Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jun 2009
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
A Phase 2 trial of MSV alogénicas in primary Sjögren's syndrome, sponsored by Nanjing Drum-Tower Hospital. Status: unknown.
02
Drugs
MSV alogénicas
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT00953485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953485.